Cargando…
Post-neoadjuvant treatment with capecitabine and trastuzumab emtansine in breast cancer patients—sequentially, or better simultaneously?
PURPOSE: Following neoadjuvant chemotherapy for breast cancer, postoperative systemic therapy, also called post-neoadjuvant treatment, has been established in defined risk settings. We reviewed the evidence for sequencing of postoperative radiation and chemotherapy, with a focus on a capecitabine an...
Autores principales: | Piroth, Marc D., Krug, David, Sedlmayer, Felix, Duma, Marciana-Nona, Baumann, René, Budach, Wilfried, Dunst, Jürgen, Feyer, Petra, Fietkau, Rainer, Haase, Wulf, Harms, Wolfgang, Hehr, Thomas, Souchon, Rainer, Strnad, Vratislav, Sauer, Rolf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801351/ https://www.ncbi.nlm.nih.gov/pubmed/32737515 http://dx.doi.org/10.1007/s00066-020-01667-z |
Ejemplares similares
-
Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward
por: Krug, David, et al.
Publicado: (2021) -
Oligometastasis in breast cancer—current status and treatment options from a radiation oncology perspective
por: Piroth, Marc D., et al.
Publicado: (2022) -
Heart toxicity from breast cancer radiotherapy: Current findings, assessment, and prevention
por: Piroth, Marc D., et al.
Publicado: (2018) -
DEGRO practical guideline for partial-breast irradiation
por: Strnad, V., et al.
Publicado: (2020) -
Current controversies in radiotherapy for breast cancer
por: Krug, David, et al.
Publicado: (2017)